Browsing Tag
GYRE
1 post
Gyre Therapeutics enrolls 272 patients in late-stage pirfenidone study targeting China’s pneumoconiosis crisis
Gyre Therapeutics completes enrollment of 272 patients in its Phase 3 pirfenidone trial for pneumoconiosis—find out how it could change treatment in China.